HOLX - Hologic - Stock Price & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4364401012
Molecular Diagnostic Assays, Mammography Systems, Surgical Instruments, X-ray Systems
Hologic, Inc. is a leading healthcare company that specializes in developing, manufacturing, and supplying a wide range of products and systems focused on women's health, diagnostics, and medical imaging. The company's mission is to improve lives through early detection and treatment of various health conditions.
The company operates through four main business segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. In the Diagnostics segment, Hologic offers a portfolio of molecular diagnostic assays, including Aptima, which detects infectious microorganisms, and viral load assays for Hepatitis B and C, HIV, and human cytomegalovirus. Additionally, the company provides assays for diagnosing vaginitis and detecting SARS-CoV-2.
In the Breast Health segment, Hologic provides a comprehensive range of solutions for breast cancer care, including 3D digital mammography systems, image analytics software, and minimally invasive breast biopsy guidance systems. The company's products are designed to support radiologists, pathologists, and surgeons in the diagnosis and treatment of breast cancer.
In the GYN Surgical segment, Hologic offers a range of products and systems for gynecological procedures, including the MyoSure Hysteroscopic Tissue Removal System for removing fibroids and polyps, and the NovaSure Endometrial Ablation System for treating abnormal uterine bleeding. The company also provides the Fluent Fluid Management System for liquid distention during hysteroscopic procedures and the Acessa ProVu system for treating fibroids.
In the Skeletal Health segment, Hologic offers the Horizon DXA, a dual energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which enables minimally invasive orthopedic surgical procedures. The company's products are designed to improve patient outcomes and reduce healthcare costs.
Hologic sells its products through a combination of direct sales, service forces, independent distributors, and sales representatives. With a strong commitment to innovation and customer satisfaction, the company has established itself as a leader in the healthcare industry. Founded in 1985, Hologic is headquartered in Marlborough, Massachusetts, and has a strong online presence at https://www.hologic.com.
Drawdown (Underwater) Chart
![Drawdown / Underwater Chart for HOLX - Hologic - Stock Price & Dividends](https://www.valueray.com/images/drawdown_chart/HOLX.NASDAQ_drawdown.png)
Overall Trend and Yearly Seasonality
![Drawdown / Underwater Chart for HOLX - Hologic - Stock Price & Dividends](https://www.valueray.com/images/chart/HOLX.NASDAQ_seasonality.png)
HOLX Stock Overview
Market Cap in USD | 18,175m |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
GiC SubIndustry | Health Care Equipment |
TER | 0.00% |
IPO / Inception | 1990-06-21 |
HOLX Stock Ratings
Growth 5y | 40.5 |
Fundamental | 47.7 |
Dividend | 0.00 |
Rel. Performance vs Sector | -0.23 |
Analysts | 3.89/5 |
Fair Price Momentum | 73.92 USD |
Fair Price DCF | 107.19 USD |
HOLX Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | 0.00% |
Dividends CAGR 5y | 0.00% |
Payout Consistency | 0.0% |
HOLX Growth Ratios
Growth 12m | -2.55% |
Growth Correlation 12m | 30% |
Growth Correlation 3m | -2% |
CAGR 5y | 9.29% |
CAGR/Mean DD 5y | 0.80 |
Sharpe Ratio 12m | -0.44 |
Alpha vs SP500 12m | -20.73 |
Beta vs SP500 5y weekly | 0.83 |
ValueRay RSI | 86.14 |
Volatility GJR Garch 1y | 15.07% |
Price / SMA 50 | 5.29% |
Price / SMA 200 | 7.08% |
Current Volume | 1472.2k |
Average Volume 20d | 1509.4k |
External Links for HOLX Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of July 27, 2024, the stock is trading at USD 78.63 with a total of 1,472,174 shares traded.
Over the past week, the price has changed by +0.67%, over one month by +8.80%, over three months by +3.49% and over the past year by -0.99%.
According to ValueRays Forecast Model, HOLX Hologic will be worth about 81.3 in July 2025. The stock is currently trading at 78.63. This means that the stock has a potential upside of +3.43%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 87.2 | 10.9 |
Analysts Target Price | 86.6 | 10.2 |
ValueRay Target Price | 81.3 | 3.43 |